Patents and Patent Applications from University of North Carolina


Match Document Document Title
US20120128647 DELIVERY OF COMPOUNDS WITH REHYDRATED BLOOD CELLS  
Fixed-dried blood cells carrying an active agent are described, along with methods of making the same, methods of using the same, and compositions containing the same. The blood cells are...
US20120122810 Fused Pentacyclic Polyethers  
Disclosed are polycyclic polyether compounds of formula I and pharmaceutical compositions comprising such compounds. wherein R, OR1, and R2 are as defined herein. Also disclosed are methods of...
US20120114554 Engineered Aerosol Particles, And Associated Methods  
An engineered aerosol particle for use in aerosol applications is provided. The engineered aerosol particle comprises a fabricated nanoparticle body member being non-spherical. The fabricated...
8173596 Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis  
A method for treating a disorder characterized by salt retention, fluid retention, and combinations thereof. A method for determining the presence of or the progression of a disorder characterized...
8165460 Coated filament for evaporation/condensation aerosol generation of therapeutic agents and methods for using  
An apparatus for generating an aerosol of a therapeutic agent and methods of using the same are disclosed. The apparatus comprises a heating element having a surface and a composition coating at...
8163151 Assays for detection of Von Willebrand factor (vWF) multimers and for degradation of vWF by agents such as Adamts13 and related methods  
Methods of analyzing the electrophoretic mobility distribution of von Willebrand factor (vWF) multimers include providing a sample medium comprising a plurality vWF multimers. The vWF multimers are...
US20120094318 E-CADHERIN AS A BIOMARKER OF GASTROESOPHAGEAL REFLUX DISEASE  
The present invention provides methods of diagnosing and identifying subjects as having GERD comprising detecting E-cadherin fragments in a biological sample from the subject. The invention further...
US20120091369 FOCUSING MULTIMODAL OPTICAL MICROPROBE DEVICES  
The present invention provides an optical microprobe device and method for focusing multimodal radiation with wavelength-scale spatial resolution and delivering the focused radiation to a specimen,...
8159219 MEMS 2D and 3D magnetic field sensors and associated manufacturing method  
The disclosure provides Hall effect device configurations capable of measuring magnetic fields in two dimensions (2D) and three dimensions (3D) along with associated microelectromechanical system...
8158728 Methods and materials for fabricating microfluidic devices  
Materials and Methods are provided for fabricating microfluidic devices. The materials include low surface energy fluoropolymer compositions having multiple cure functional groups. The materials...
8158347 Determination of molecular age by detection of INK4a/ARF expression  
The presently disclosed subject matter provides methods for determining the molecular age of a tissue. Also provided are methods for employing a molecular age that has been determined for a tissue...
8156829 Methods of acoustic measurement and control of pharmaceutical sprays  
Methods of modulating a characteristic of a pharmaceutical compound spray by acoustic measurement and control of the pharmaceutical spray are disclosed. The methods include analyzing a selected...
8155262 Methods, systems, and computer program products for multiplexing computed tomography  
Methods, systems, and computer program products for multiplexing computed tomography are disclosed. According to one aspect, the subject matter described herein can include illuminating an object...
8153589 JNK3 as a target for the treatment of angiogenesis-related diseases  
Provided herein are methods for treating a subject having or at risk for an angiogenesis-related disorder. The methods include administering to the subject a therapeutically effective amount of an...
8152305 Methods, systems, and computer program products for full spectrum projection  
A broadband electromagnetic wave beam is projected from a broadband wave source (301). The wave beam is separated by an element (306) into narrowband wavelength beams. The narrowband beams are...
8150111 Methods, systems, and computer program products for processing three-dimensional image data to render an image from a viewpoint within or beyond an occluding region of the image data  
Methods, systems, and computer program products for processing three-dimensional image data to render an image from a viewpoint within or beyond an occluding region of the image data are disclosed....
8148511 Methods and compositions for the detection and quantification of E. coli and Enterococcus  
The present invention is drawn to methods and compositions for the rapid assessment of fecal indicator bacteria in a sample. Provided herein are novel primer and probe compositions for use in...
8145585 Automated methods and systems for the detection and identification of money service business transactions  
The present disclosure provides an automated method for the detection and identification of money service business transactions, including: performing a preprocessing operation, wherein the...
8138200 Compositions and methods for double-targeting virus infections and targeting cancer cells  
The invention includes compositions and methods useful for treatment of a virus infection in a mammal by double-targeting the virus (i.e. targeting the virus at more than one stage of the virus...
8137914 Variants of alpha-fetoprotein coding and expression sequences  
The invention discloses the sequences of variant forms of alpha-fetoprotein transcripts that have been identified in human hemopoietic progenitors but not in differentiated mature cells. The...
US20120064128 NANO-METALLIC ALLOY DELIVERY SYSTEM FOR TREATMENT OF INFECTED CELLS AND LEGIONS  
A system for delivering nano-metallic alloys to infected cells in a patient is disclosed. The nano-metallic alloy may be formed from binary, triple, or quadruple elemental compositions complexed in...
US20120064075 CHIMERIC FACTOR VII MOLECULES WITH ENHANCED HALF LIFE AND METHODS OF USE  
The present invention relates to novel proteins and methods of using chimeric Factor VIIa polypeptides.
US20120050528 DIMENSIONAL MEASUREMENT THROUGH A COMBINATION OF PHOTOGRAMMETRY AND OPTICAL SCATTERING  
A system for determining the position and location of a module comprising: a module which includes an optical generator which generates an optical beam; a diffractive element placed in the path of...
8124393 Compositions and methods for inducing or inhibiting activities of selected human cells  
Polynucleotides encoding a mutant human carboxylesterase enzyme and polypeptides encoded by the polynucleotides which are capable of metabolizing a prodrug and inactive metabolites thereof to...
US20120046394 HEMP FIBER REINFORCED COMPOSITE WITH RECYCLED HIGH DENSITY POLYETHYLENE AND PRODUCTION THEREOF  
Novel structural materials composed of industrial hemp fiber with recycled high density polyethylene (HDPE) as well as methods for the production of the same are disclosed. The material's...
8119589 Modulation of CD4+ T cell responses by a tick saliva protein, Salp15 and polypeptides derived therefrom  
Salp15, biologically functional equivalents and fragments thereof, and nucleic acid molecules encoding the same are disclosed. Recombinant host cells, recombinant nucleic acids and recombinant...
8119392 Biocompatible resists  
This invention relates to biomaterials, biocompatible photoresists, and electroactive photoresists, and methods to engineer the interactions between biomaterials and cells. In one aspect, this...
US20120039896 METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1  
A method of inhibiting cellular activation by Insulin-like Growth Factor-1 (IGF-1) in a subject in need thereof (e.g., a subject afflicted with cancer, atherosclerosis, diabetic retinopathy or...
US20120034169 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS  
The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
US20120031451 HIGH TEMPERATURE THERMOELECTRIC GENERATOR  
The present invention relates to a high temperature thermoelectric generator. The generator includes at least one thermocouple thermally connected to a high temperature surface, a power management...
US20120028353 HEPATIC STELLATE CELL PRECURSORS AND METHODS OF ISOLATING SAME  
The present invention relates to precursor cells to hepatic stellate cells, compositions comprising same and methods of isolating same. The surface antigenic profile of the precursors is MHC class...
US20120027278 METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR MAPPING REGIONS IN A MODEL OF AN OBJECT COMPRISING AN ANATOMICAL STRUCTURE FROM ONE IMAGE DATA SET TO IMAGES USED IN A DIAGNOSTIC OR THERAPEUTIC INTERVENTION  
Methods, systems, and computer readable media for mapping a model of an object comprising an anatomical structure in a planning image and an intervention target region within it to...
8106032 Lipid analogs for combating tumors  
The invention relates to methods of treating viral infections, and in particular hepatitis B virus. The method comprises administering to a subject in need of such treatment an...
US20120021055 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS  
The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
8101636 Linear dicationic terphenyls and their aza analogues as antiparasitic agents  
Novel aza analogues of dicationic terphenyl compounds for use in combating microbial infections are described. Also described are processes for synthesizing the compounds. The presently disclosed...
8101191 Mycobacterial SecA2 mutants  
Provided are mycobacteria comprising (a) a mutation that is not in a SecA2 gene that attenuates the virulence of the mycobacteria in a mammalian host, and (b) a mutation in a SecA2 gene that...
8097410 Methods and compositions for vitamin K epoxide reductase  
The present invention provides a method of identifying a human subject having increased or decreased sensitivity to warfarin, comprising detecting in the subject the presence of a single nucleotide...
US20120009268 Modified Virus Vectors and Methods of Making and Using the Same  
The present invention provides AAV capsid proteins (VP1, VP2 and/or VP3) comprising a modification in the amino acid sequence in the three-fold axis loop 4 and virus capsids and virus vectors...
8090164 Systems, methods, and computer program products for analysis of vessel attributes for diagnosis, disease staging, and surgical planning  
Systems, methods, and computer program products for analysis of vessel attributes for diagnosis, disease staging, and surgical planning are disclosed. A method for analyzing blood vessel attributes...
US20110315219 EFFICIENCY ENHANCEMENT OF SOLAR CELLS USING LIGHT MANAGEMENT  
A photovoltaic cell includes a junction, formed from an n-type semiconductor material and a p-type semiconductor material, a trench, opening toward the light-incident side of the junction, for...
US20110313718 Construction Modulus Testing Apparatus and Method  
A system and method of determining lift deflection during construction of aggregate columns allows for real time monitoring of construction to ensure meeting defined parameters. The amount of...
US20110306878 INTERVENTIONAL DRUG DELIVERY SYSTEM AND ASSOCIATED METHODS  
A delivery system for local drug delivery to a target site of internal body tissue is provided. The delivery system comprises a source electrode adapted to be positioned proximate to a target site...
US20110301583 NON-INVASIVE LASER VASECTOMY  
The present invention presents novel methods for performing noninvasive vasectomies in animals, including humans, and vasectomy clamps for use in such procedures. The invention further presents an...
US20110301228 GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA  
The presently disclosed subject matter provides an inducible vector comprising a therapeutic gene. In some embodiments a method is provided for treating steroid glaucoma. In some embodiments a...
8071559 Compositions and methods for cancer diagnosis and treatment  
The application relates to methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the mir17-92 cluster. The...
8067375 Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor  
Methods of treating a demyelinating disorder using inhibitors of the lymphotoxin pathway.
US20110284805 PRODUCTION OF MECHANICALLY EXFOLIATED GRAPHENE AND NANOPARTICLE COMPOSITES COMPRISING SAME  
A method for producing nanospacer-graphene composite materials (i.e., mechanically-exfolitated graphene), wherein the graphene sheets are interspersed with nanospacers, thereby maintaining the 2D...
8065089 Methods and systems for analysis of dynamic biological pathways  
Disclosed is a hierarchical computational method to predict the expression value of genes in time-series microarray data. The method may include the step of first applying a nonlinear independent...
US20110274666 METHOD OF ENGRAFTING CELLS FROM SOLID TISSUES  
A method of repairing diseased or dysfunctional organs or of establishing a model system of a disease state is provided. For repairing diseased organs, the method involves engraftment of cells from...
8048644 Biological indicator for monitoring the transport of micro-organisms in the environment  
A method of using a biological indicator to detect and identify sources of fecal contamination such as leaking sewer lines, septic tanks, and holding lagoons, using a microorganism having a...